Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Okoro Emmanuel

Okoro Emmanuel

University of Ilorin, Nigeria

Title: PRECISION MEDICINE: A strategic tool for resource optimization in diabetes care

Biography

Biography: Okoro Emmanuel

Abstract

Precision medicine can improve care and lower cost by matching each group/ individual with what work best for each.  Already even without widespread genetic testing, mortality - related to type2diabetes / hypertension is plunging in Europe /North America from effective interventions. In contrast mortality remains alarmingly high locally just as the same anti-atherosclerotic therapies dominate Nigeria market.  Coincidentally,  unlike in Europe/North America  where over  70% of deaths in  type2diabetes/hypertension usually  result  from atherosclerosis no more than 0.6-2% of affected  Nigerians generally experience  such outcomes despite frequent ( 70-90%) dyslipidaemia  including elevated cholesterol in  such groups.  Intriguingly , an unusual cooperation between elements in academia,  industry and  regulators  means  this  biologic advantage  for delivering  superior cardiovascular care in type2diabetes  at a  lower cost compared to jurisdictions where occlusive atherosclerosis is  frequent is being overlooked .The result is an epidemic of overtreatment which expose  the affected population to the risk of  paying   the highest possible cost for the worst possible care when  cheaper alternatives that  can save more lives  through better  BP reduction are widely available .  Specifically, the astronomical rise in  outpatient treatment cost  from under  N2000 in 2000  to   N56,2450  monthly  as at 2013  results predominantly (> 90% )  from  interventions/ tests of largely unproven health benefits to local  population but couched as  national best practice.    And Nigeria remains the largest health market of blacks globally currently estimated at 190 million and projected to become the third most populous nation by 2050 after India and China.  With 30-40% of this population having hypertension /type2diabetes this is a huge marketing opportunity for effective/affordable treatments that can keep poor people alive and turn them into paying customers.